The Latest Breaking News from Eli Lilly

Eli Lilly experienced a "bump in the road" for its newest diabetes treatment, Mounjaro, an analyst said Thursday as LLY stock toppled.

The Dow Jones fell Thursday after initial jobless claims. Meta stock soared 20% on a $40 billion stock buyback.

Eli Lilly shares slipped Friday morning after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment

"We are committed to working with the FDA to ensure the fastest possible path to bring this potential medicine to patients in need," Eli Lilly said.

Stock futures mixed with Fed talk, earnings in focus; Netflix surges as blowout subscriber gains offset earnings miss; Costco shares gain as bulk retail unveils $4 billion buyback plan; Nordstrom slumps after slashing profit forecast following weak holiday sales and Eli Lilly slides as FDA rejects fast track review of…

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday.

California says it will sue the companies that make and promote much of the nation's insulin

There's a large pipeline of promising yet expensive drugs that could get approved.